Telos Capital Management Inc. Acquires 1,879 Shares of Danaher Corporation $DHR

Telos Capital Management Inc. lifted its holdings in Danaher Corporation (NYSE:DHR) by 4.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 47,160 shares of the conglomerate’s stock after purchasing an additional 1,879 shares during the period. Telos Capital Management Inc.’s holdings in Danaher were worth $9,316,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Sierra Ocean LLC increased its stake in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the period. Red Tortoise LLC increased its stake in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Ramirez Asset Management Inc. bought a new position in shares of Danaher in the second quarter worth about $40,000. Costello Asset Management INC bought a new position in shares of Danaher in the first quarter worth about $41,000. Finally, Mowery & Schoenfeld Wealth Management LLC increased its stake in shares of Danaher by 53.8% in the first quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock worth $42,000 after purchasing an additional 71 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Up 0.3%

NYSE DHR opened at $215.63 on Monday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock’s 50 day moving average is $203.41 and its two-hundred day moving average is $199.60. The company has a market capitalization of $152.31 billion, a price-to-earnings ratio of 44.46, a PEG ratio of 3.28 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company’s quarterly revenue was up 4.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were issued a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio is currently 26.39%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Guggenheim restated a “buy” rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Bank of America lowered their price target on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Barclays boosted their price target on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, JPMorgan Chase & Co. boosted their price target on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.